Skip to main content
. 2022 Nov 12;10(6):150. doi: 10.3390/pharmacy10060150

Table 4.

Readiness to Offer OTC Hearing Aids.

Question Category Respondents (% *)
I have the necessary knowledge to counsel patients on OTC hearing aids (n = 85) Strongly disagree 37 (43.5)
Disagree 20 (23.5)
Neutral 21 (24.7)
Agree 5 (5.9)
Strongly agree 2 (2.4)
Patients in my community would purchase OTC hearing aids at a community pharmacy for their personal use (n = 85) Strongly disagree 4 (4.7)
Disagree 3 (3.5)
Neutral 19 (22.4)
Agree 37 (43.5)
Strongly agree 22 (25.9)
Expected supporting factors as OTC hearing aids become available a (n = 82) Training and educational resources for pharmacy staff 70 (85.4)
Professional connections to hearing health care professionals like audiologists 51 (62.2)
Expertise of pharmacy colleagues 49 (59.8)
Support from place of employment 44 (53.7)
Supportive leadership 28 (34.2)
Culture or mission of place of employment 23 (28.1)
Affiliation with research institutions 10 (12.2)
Other 2 (2.4)
Expected barriers as OTC hearing aids become available a (n = 82) Pharmacist time and workflow constraints 76 (92.7)
Available training and/or continuing education for pharmacists 54 (65.9)
Level of pharmacist expertise 54 (65.9)
Staff resources 48 (58.5)
Patient understanding of appropriate OTC hearing aid use 34 (41.5)
Support from place of employment 34 (41.5)
Patient interest in use of OTC hearing aids 20 (24.4)
Other 2 (2.4)
When prepared to assist patients with OTC hearing aids, if available today (n = 81) Within 30 days 36 (44.4)
Within 6 months 28 (34.6)
Within 1 year 1 (1.2)
After 1 or more years 0 (0.0)
I do not intend to offer OTC hearing aids at my pharmacy 9 (11.1)
Not applicable 7 (8.6)
Benefits to offering OTC hearing aids at the pharmacy a (n = 81) Improved patient access to hearing aids 71 (87.7)
Flexible treatment options 61 (75.3)
Increased patient interest in the use of hearing aids 42 (51.9)
Increased revenue at my place of employment 35 (43.2)
Reduction of health risks associated with hearing loss 33 (40.7)
Other 1 (1.2)
None 4 (4.9)
Concerns about offering OTC hearing aids at the pharmacy a (n = 81) Improper or unsafe use by patients 54 (66.7)
Increased personal or professional liability 37 (45.7)
Quality of research on OTC hearing aid safety and effectiveness 32 (39.5)
Lack of patient trust in new technology 20 (24.7)
Other 5 (6.2)
None 9 (11.1)

* Totals may not add to 100% due to rounding. a Respondents selected all choices that applied.